Survivin, Ki-67 and tumor grade as predictors of response to docetaxel-based neoadjuvant chemotherapy in locally advanced breast cancer

Lignende værker

• Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
  af: Kim, Kwan Il, et al.
  Udgivet: (2014)
• Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
  af: Prihantono, Prihantono, et al.
  Udgivet: (2017)
• Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
  af: Chen, Rui, et al.
  Udgivet: (2018)
• Association of Ki-67 Expression and Response of Neoadjuvant Chemotherapy in Invasive Breast Cancer Patients in Bandung
  af: Andri Rezano, et al.
  Udgivet: (2018-09-01)
• Decrease in the Ki67 index during neoadjuvant chemotherapy predicts favorable relapse-free survival in patients with locally advanced breast cancer
  af: Chunfa Chen, et al.
  Udgivet: (2019-09-01)